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Abstract
Purpose Myocardial contusion can be a life-threatening condition in patients who sustained blunt thoracic trauma. The 
diagnostic approach remains a subject of debate. The aim of this study was to determine the sensitivity and specificity of 
echocardiography, electrocardiography, troponins T and I (TnT and TnI), and creatine kinase muscle/brain (CK-MB) for 
identifying patients with a myocardial contusion following blunt thoracic trauma.
Methods Sensitivity and specificity were first determined in a 10-year retrospective cohort study and second by a systematic 
literature review with meta-analysis.
Results Of the 117 patients in the retrospective study, 44 (38%) were considered positive for myocardial contusion. Chest 
X-ray, chest CT scan, electrocardiograph, and echocardiography had poor sensitivity (< 15%) but good specificity (≥ 90%). 
Sensitivity to cardiac biomarkers measured at presentation ranged from 59% for TnT to 77% for hs-TnT, specificity ranged 
from 63% for CK-MB to 100% for TnT. The systematic literature review yielded 28 studies, with 14.5% out of 7242 patients 
reported as positive for myocardial contusion. The pooled sensitivity of electrocardiography, troponin I, and CK-MB was 
between 62 and 71%, versus only 45% for echocardiography and 38% for troponin T. The pooled specificity ranged from 
63% for CK-MB to 85% for troponin T and 88% for echocardiography.
Conclusion The best diagnostic approach for myocardial contusion is a combination of electrocardiography and measure-
ment of cardiac biomarkers. If abnormalities are found, telemonitoring is necessary for the early detection of life-threatening 
arrhythmias. Chest X-ray and CT scan may show other thoracic injuries but provide no information on myocardial contusion.
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Background
Myocardial contusion describes a condition of bruising or 
(microscopically small) hemorrhaging of the heart muscle 
caused by blunt thoracic trauma. In patients who have sus-
tained blunt thoracic trauma, the prevalence of myocardial 
contusion ranges from 0 to 76%, depending on the diag-
nostic criteria used [1–10].
The bruising is generally caused by a decelerating force 
on the anterior side of the thorax [11–14]. First, the heart 
is abruptly pressed to the dorsal side of the sternum caus-
ing a bruise on the anterior side (‘coup’). Depending on 
the amount of energy that needs and can be absorbed by 
the rib cage, the thoracic spine can hit the heart at the pos-
terior side, resulting in a second bruise (‘contrecoup’). In 
a final stage, the distance between the sternum and spine 
will reduce further, resulting in septal or intracardiac 
structural injuries.
The absence of a clear definition and the fact that there 
is no accepted gold standard in complementary tests makes 
diagnosing myocardial contusion difficult. The diagnostic 
approach of myocardial contusion as well as its clinical 
course remain subject to debate, because of heterogene-
ity in clinical presentation and the unpredictable natural 
course [1, 15–20]. The decelerating force can not only 
lead to mechanical cardiac injuries, such as rupture of 
atria or chordae, the bruising may also lead to other car-
diac adverse events, varying from mild arrhythmias like 
premature ventricular complexes, to atrial fibrillation or 
ventricular fibrillation [2–5, 11–16]. The vast majority of 
patients who develop arrhythmia after a myocardial contu-
sion do so within 24 h after trauma [13, 21–25]. Whereas 
on admission to the emergency department a large propor-
tion of patients who sustained blunt thoracic trauma do not 
show cardiac symptoms indicative of myocardial contu-
sions, clinicians should be prepared for rapid changes in 
clinical condition of such patients as severe arrhythmia or 
even cardiac arrest can occur within 72 h [26, 27].
Myocardial contusion is often accompanied by significant 
extracardiac injuries which may have hemodynamic effects, 
thereby hampering the possible diagnosis of a myocardial 
contusion. Patients with hemodynamic changes but with-
out a clear bleeding or cardiac tamponade are very suspect 
for myocardial contusion [8, 14, 24]. On the other hand, 
pulmonary contusion, a sternum fracture, or multiple rib 
fractures should warn the treating physician to be aware of 
a possible myocardial contusion. Therefore, the relevance of 
complete diagnostics should not be underestimated after typ-
ical trauma mechanisms, even when the first impression on 
patient’s clinical condition does not indicate severe injury.
Although several diagnostic tests are available, none 
of them have shown sufficient diagnostic accuracy for 
diagnosing myocardial contusion [19, 22, 28–32]. Espe-
cially for patients who sustained a high-energy trauma but 
have no clear symptoms or signs (yet), selecting those who 
require careful observation or telemonitoring from those 
who can go home safely, is paramount. Echocardiography 
and electrocardiography may indicate damage to the tissue 
architecture and subsequent complications, but informa-
tion on specific cellular damage within the heart muscle 
requires measurement of cardiac muscle-specific proteins 
such as troponin T (TnT), troponin I (TnI), or creatine 
kinase muscle and brain isoenzyme (CK-MB) [2, 28, 29, 
33–39]. Since tissue damage cannot occur without cellular 
damage, whereas the opposite can, a combination of tests 
is commonly performed.
However, no consensus exists in the optimal diagnostic 
workup for patients with a possible myocardial contusion. 
To develop a diagnostic protocol, more insight into the diag-
nostic properties of the tests available is needed. Therefore, 
the aim of this study was to determine sensitivity and speci-
ficity of echocardiography, electrocardiography, troponins 
T and I, and CK-MB to identify patients with a myocardial 
contusion following blunt thoracic trauma. This was done 
both in a retrospective cohort and by systematic literature 
review with a meta-analysis.
Methods
Retrospective cohort study
Patients presented to a level I trauma center with a suspected 
myocardial contusion after blunt force thoracic trauma 
between January 1, 2007, and June 30, 2017, were consid-
ered eligible for this single-center retrospective cohort study. 
The study was exempted by the local Medical Research Eth-
ics Committee.
Potentially eligible patients (i.e., patients for whom 
myocardial contusion could have been considered) were 
identified using two strategies. Searching electronic hospi-
tal discharge letters and correspondence to General Prac-
titioners that mentioned myocardial contusion (or any 
synonym possible) resulted in a list of admitted and non-
admitted patients. Patients who were admitted to the hos-
pital were also identified from the National Trauma Regis-
try by searching for patients with a registered Abbreviated 
Injury Score (AIS) for any myocardial injury. The AIS-
1998 codes were 441099.1, 441002.1, 441004.1, 441006.4, 
441008.3, 441010.3, 441012.5, 441014.6, 441016.6, 
441018.6, 441200.5, and 441300.5. The AIS-2005 codes 
were 441089.9, 441099.1, 441002.1, 441004.1, 441006.4, 
114008.3, 441010.3, 441012.5, 441013.5, 441014.6, 
441016.6, 441018.6, 441200.5, 441300.5, and 440400.5. 
Two authors (DJTVS and EAD) identified the eligible 
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patients from these lists. All patients in whom a myocar-
dial contusion was considered were included. Considera-
tion of a myocardial contusion had to be clear from the 
physician’s notes in the patient’s medical files and could 
due to results of anamnesis or diagnostic tests. Exclusion 
criteria were (1) no suspicion of myocardial contusion; (2) 
trauma mechanism other than blunt trauma; (3) confirmed 
(non)-ST elevation myocardial infarction [(non-)STEMI]; 
(4) no diagnostic or outcome data available.
Patient characteristics, injury characteristics, results 
from patient history, physical examination, diagnostic tests 
(chest CT-scan, chest X-ray, electrocardiography, echo-
cardiography, and levels of cardiac biomarkers) were col-
lected from medical records. During hospital stay, relevant 
findings during clinical and telemetric observation, elec-
trocardiography, transthoracic echocardiography, levels of 
cardiac biomarkers, cardiac adverse events, mortality, and 
surgical interventions were also collected from the patient’s 
medical files. Patient characteristics included gender, age at 
trauma, comorbidities, use of medication that either mask or 
cause cardiac arrhythmia, and renal function (i.e., eGFR at 
admission). Thoracic injury characteristics are rib fractures, 
hemothorax, pneumothorax, cardiac valve defects, sternum 
fracture, flail chest, pulmonary contusion, and aorta dissec-
tion. Details on patient history and physical examination 
were complaints of chest pain, palpitations, dyspnea, faint-
ing, cardiac murmurs, cardiac rubbing, oxygen saturation, 
heart rate, systolic and diastolic blood pressure, and Glas-
gow Coma Score.
Diagnostic tests were checked for signs of abnormali-
ties. For chest CT and X-ray, suspicion of the presence of 
pericardial effusion was collected from the radiology report. 
Electrocardiograms (ECGs) were reviewed by a cardiolo-
gist (EAD) for signs of ST elevation, ST depression, T-wave 
inversion, arrhythmia, or intraventricular conduction abnor-
malities. Transthoracic echocardiography was reviewed 
(by EAD) for signs of regional wall motion abnormali-
ties, pericardial effusion, or mechanical abnormalities. No 
transesophageal echocardiography was performed.
Thresholds for increased levels of cardiac biomarkers 
were 30 ng/L for normal-sensitive troponin T (used until 
December 31, 2012) and 14 ng/L for high-sensitive troponin 
T (used since January 1, 2013). Cut-off values for creatine 
kinase MB (CK-MB) were 7.6 µg/L for men and 4.7 µg/L 
for women.
Relevant findings during clinical observation with or 
without telemetry, levels of cardiac biomarkers, electrocar-
diography, echocardiography, and cardiac adverse events 
that might suggest myocardial contusion were registered. 
Relevant cardiac adverse events were arrhythmias (i.e., atrial 
fibrillation or flutter, premature ventricular complexes, and 
supraventricular tachycardia), hypotension, and cardio-
genic shock requiring inotropic support. In addition, data 
on relevant surgical interventions, its outcome, and mortality 
were collected.
Based upon all available data and final judgement of the 
treating physician as mentioned in the patient’s medical 
files, patients were categorized as having had a myocardial 
contusion or not. Diagnostic tests were also categorized 
as positive or negative for myocardial contusion. No sin-
gle test could serve as a gold standard for the diagnosis. 
Signs indicative of myocardial contusion are (1) elevated 
cardiac biomarkers; (2) new valve defects, regional wall 
motion abnormalities, pericardial effusion, or other anatomi-
cal defects seen on echocardiography; (3) intraventricular 
conduction abnormalities, atrial fibrillation, premature ven-
tricular complexes, and supraventricular tachycardia seen on 
electrocardiography.
Data were analyzed using the Statistical Package for the 
Social Sciences version 24.0 (SPSS, Chicago, IL, USA) and 
MedCalc (https ://www.medca lc.org/calc/diagn ostic _test.
php). Patients with versus patients without myocardial con-
tusion were compared. Normality of continuous data was 
tested with the Shapiro–Wilk test, which showed that all 
were non-normally distributed. Continuous data are shown 
as median with quartiles and categorical data are shown as 
numbers with percentage. Statistical significance between 
the two groups was assessed using a Mann–Whitney U test 
for continuous data and a Chi-square test or Fisher exact test 
for categorical data. A two-sided p value < 0.05 was used as 
threshold of statistical significance. For each diagnostic test, 
myocardial contusion prevalence, sensitivity, and specificity 
were calculated and are reported as percentage with 95% 
confidence.
Literature review
A literature search was performed on November 11, 
2018, using Embase.com, Medline Ovid, Web of Science, 
Cochrane CENTRAL and Google Scholar databases. Data-
bases were searched since their inception. The full search 
string is shown in Supplemental Figure S1. Studies were eli-
gible for inclusion if they discussed tests applied to patients 
with a suspected myocardial contusion after blunt thoracic 
trauma. If no ‘myocardial contusion’ and ‘non-myocardial 
contusion’ group were mentioned, or if the diagnostic test 
that differentiated between the two groups was not known, 
the study was excluded. Studies on pediatric patients, ani-
mal studies, non-English studies, systematic reviews, meta-
analyses, descriptive studies, and case reports were also 
excluded.
Literature selection and data extraction were done by two 
authors (DJTVS and EAD) independently. Any disagree-
ment was resolved by consensus. First, titles and abstracts 
of all manuscript were reviewed for eligibility. Next, the full 
text of all remaining studies was screened for eligibility. For 
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all included studies, the reference list was reviewed for iden-
tifying studies that were missed during the selection process.
Risk of bias assessment and applicability concerns for 
each study was carried out using the QUADAS-2 tool. For 
each study, the following data were extracted: author, pub-
lication year, study design, study population size, mean age, 
number of patients diagnosed with myocardial contusion, 
and the number of patients with ischemic heart disease or 
acute myocardial infarction. For echocardiography, electro-
cardiography, and cardiac biomarkers, the number of true 
and false positives and negatives were extracted for each 
study. In addition, the reference test and cut-off values for 
cardiac biomarkers used for identifying the myocardial con-
tusion group were recorded.
Sensitivity and specificity were calculated using Review 
Manager (RevMan version 5.3, Copenhagen; The Nordic 
Cochrane Center, The Cochrane Collaboration, 2014). Sub-
sequent meta-analysis was done using Meta-analysis of 
Diagnostic and Screening Tests (Meta-DiSc) [40]. Sensitiv-
ity and specificity were pooled across all studies, and a sum-
mary receiver operating curve was made. For each different 
diagnostic test, sensitivity and specificity are reported as 
percentage with 95% confidence interval. The area under the 




A total of 611 patients were identified by searching the hos-
pital database (n = 372) and the trauma registry (n = 239; 
Fig. 1). After studying the electronic medical records, 494 
patients were excluded: 378 patients had not been suspected 
for myocardial contusion, 57 had not sustained blunt tho-
racic trauma, 21 had a confirmed myocardial infarction, 
and for 38 patients, diagnostic or outcome data were not 
available. The remaining 117 patients were admitted with 
a suspicion of myocardial contusion. Forty-four were diag-
nosed with a myocardial contusion and 73 were not. The 
study population had a median age of 43  (P25–P75 31–62) 
years (Table 1), 83 (71%) patients were male and 16 (14%) 
had a known unrelated (cardiopulmonary) disorder. These 
patient characteristics at presentation did not differ between 
patients with myocardial contusion and those without myo-
cardial contusion, nor did kidney function. Three patients 
used either citalopram, paroxetine, or methadone.
The rate of non-cardiac thoracic injuries was higher in 
patients with a myocardial contusion (n = 40; 91%) than in 
those who were not diagnosed with a myocardial contusion 
(n = 54; 74%; p = 0.031). The four most common injuries 
were a sternum fracture, rib fracture(s), pneumothorax, and 
pulmonary contusion. Rib fractures occurred more often in 
patients with a myocardial contusion than patients without 
(68% versus 42%; p = 0.008). The same was true for pulmo-
nary contusion (43% versus 23%; p = 0.038). Rates of all 
other thoracic injuries were similar in both groups.
Details of patient history could be found for 80% of 
patients; 39 (41%) patients had chest pain, 4 (4%) had 
dyspnea, 1 (1%) had palpitations, and none had cardiac 
rubbing (Table 2). None of these differed between the two 
groups. Results of physical examination were available for 
all 117 patients. Patients with a myocardial contusion had 
a higher median heart rate (97 bpm;  P25–P75 82–114 versus 
80;  P25–P75 72–92; p < 0.001), a lower median mean arte-
rial pressure (MAP) (94 mmHg; P25–P75 73–107 versus 
100 mmHg; P25–P75 94–110; p = 0.037), and a lower median 
Glasgow Coma Scale (15; P25–P75 5–15 versus 15; P25–P75 
15–15; p = 0.001).
Chest CT scan, electrocardiography, and transthoracic 
echocardiography made at hospital presentation were indica-
tive of myocardial contusion in only one patient who showed 
retrosternal hematoma (Table 2). Five patients without myo-
cardial contusion also showed retrosternal hematoma on the 
CT scan. Chest X-ray was unremarkable in all patients. On 
the other hand, levels of cardiac biomarkers TnT, hs-TnT, 
and CK-MB were consistently higher in patients with a myo-
cardial contusion than in patients without.
Overall, 111 patients with a suspected myocardial con-
tusion were admitted for observation. Telemonitoring was 
done in 91% of patients with a myocardial contusion versus 
59% of patients without myocardial contusion (p < 0.001). 
Abnormalities suggestive of myocardial contusion at the 
electrocardiography made during admission were shown 
only in one patient with a myocardial contusion. Levels of 
cardiac biomarkers remained higher at follow-up in patients 
with a myocardial contusion than in patients without, as was 
the case in the initial screening.
The diagnostic properties for myocardial contusion of 
all diagnostic tests evaluated performed at presentation and Fig. 1  Flowchart of retrospective cohort study
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during follow-up are shown in Table 3. Chest X-ray, chest 
CT scan, electrocardiography, and echocardiography all had 
a poor sensitivity (< 15%) but a good specificity (≥ 90%). 
Diagnostic performance is much better for the cardiac bio-
markers. Sensitivity ranged from 59% for TnT to 77% for hs-
TnT, measured at presentation. Repeated cardiac biomarkers 
even had a sensitivity of 86% for TnT and 93% for hs-TnT. 
Specificity for measurements at presentation and follow-up 
was excellent for TnT (100% and 93%) and good for hs-TnT 
(85% and 81%), but moderate to poor for CK-MB (63% and 
44%). Plot of the cardiac biomarkers over time for patients 
with myocardial contusion that did not have elevated marker 
expression at presentation is shown in Fig. 2. This shows that 
six out of nine patients with normal TnT values at presenta-
tion had elevated TnT expression at both repeated meas-
urements (Fig. 2a). Likewise, four out of five patients with 
normal hs-TnT expression at presentation had elevated levels 
at follow-up (Fig. 2b). For CK-MB, four out of seven males 
and both females had elevated CK-MB expression, following 
normal expression at presentation (Fig. 2c, d).
Thirty-three cardiac adverse events had developed in 18 
patients (Table 4). Patients with myocardial contusion had 
a larger rate of cardiac adverse events (n = 15; 34%) than 
controls (n = 3; 4%; p < 0.001). The most common adverse 
event was arrhythmia, which was seen in 13 patients with 
a myocardial contusion (versus two in patients without 
myocardial contusion). Eight of these 13 patients with 
a myocardial contusion had atrial fibrillation or flutter. 
Rib fractures occurred more often in patients who devel-
oped an adverse event: 12 out of 18 (67%) patients with 
an adverse event had fractured ribs, versus 49 out of 99 
(49%) in patients who remained free of adverse events. 
Seven patients died, four patients with a myocardial contu-
sion and three patients without myocardial contusion. Of 
the patients with myocardial contusion, one patient died 
of cardiogenic shock due to a known mitral valve dysfunc-
tion; in two other patients, treatment was stopped due to 
infaust neurological prognosis after trauma. In the fourth 
patient, no cause of death was noted and autopsy was not 
performed. One patient without myocardial contusion died 
of pulmonary embolism, the other two due to infaust neu-
rological prognosis after trauma.
Table 1  Patient and injury 
characteristics of patients with 
versus without myocardial 
contusion
Data are shown as n (%) or median  (P25–P75)
eGFR estimated glomerular filtration rate, ND not determined
a None of the patients had used amiodarone, haloperidol, flecainide, sotalol, macrolide antibiotics, cotri-
moxazole, amitriptyline, bupropion, fluoxetine, sertraline, venlafaxine, domperidone, or ondansetron
Parameter Overall (n = 117) Myocardial con-
tusion (n = 44)
No myocardial 
contusion (n = 73)
p value
Patient characteristics
 Male gender 83 (71%) 34 (77%) 49 (67%) 0.296
 Age 43 (31–62) 39 (23–64) 46 (34–61) 0.518
 Comorbidity 16 (14%) 5 (11%) 11 (15%) 0.782
  Cardiac 14 (12%) 4 (9%) 10 (14%) ND
  Pulmonary 3 (3%) 2 (5%) 1 (1%) ND
  Kidney transplant 1 (1%) 1 (2%) 0 (0%) ND
 Medicationa 3 (3%) 0 (0%) 1 (4%) 0.290
  Citalopram 1 (1%) 0 (0%) 1 (1%) ND
  Paroxetine 1 (1%) 0 (0%) 1 (1%) ND
  Methadone 1 (1%) 0 (0%) 1 (1%) ND
 eGFR at admission (mL/minute) 90 (75–105) 89 (68–107) 90 (79–104) 0.566
Thoracic injuries
 Thoracic injury 94 (80%) 40 (91%) 54 (74%) 0.031
 Sternum fracture 67 (57%) 23 (52%) 44 (60%) 0.443
 Rib fracture 61 (52%) 30 (68%) 31 (42%) 0.008
 Pneumothorax 40 (34%) 19 (43%) 21 (29%) 0.159
 Pulmonary contusion 36 (31%) 19 (43%) 17 (23%) 0.038
 Hemothorax 18 (15%) 10 (23%) 8 (11%) 0.114
 Flail chest 6 (5%) 2 (5%) 4 (5%) 1.000
 Aorta rupture 2 (2%) 2 (5%) 0 (0%) ND
 Valve abnormalities 1 (1%) 1 (2%) 0 (0%) ND
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Literature review
The search strategy resulted in 3443 records, of which 1665 
remained after removing duplicates (Fig. 3). After applying 
inclusion criteria to title and abstract, 117 records remained. 
Of these, 91 had to be excluded based upon the exclusion 
criteria. Review of reference lists of the 26 included manu-
script yielded 2 studies that were missed in the selection 
process. Details on the 28 included manuscripts are shown in 
Supplemental Table S1 [2, 3, 8, 14, 21–23, 35–37, 41–58]. 
Table 2  Results from 
patient history and physical 
examination of patients with 
versus without myocardial 
contusion
Data are shown for the diagnostic modalities at presentation to hospital
Troponin I is not shown, as it was measured in one patient (who had myocardial contusion) at presentation, 
and in none at follow-up
Data are shown as n (%) or as median  (P25–P75)
Bpm beats per minute, CI confidence interval, CK-MB creatine kinase, muscle and brain isoenzyme, CT 
computed tomography, ECG electrocardiography, Hs-TnT high sensitive troponin T, MAP mean arterial 
pressure, ND not determined, TTE transthoracic echocardiography
Parameter Overall (n = 117) Myocardial con-
tusion (n = 44)
No myocardial 
contusion (n = 73)
p value
Diagnostic item at presentation
 Patient history recorded 94 (80%) 30 (68%) 64 (88%) 0.016
  Chest pain 39/94 (41%) 9/30 (30%) 30/64 (47%) 0.178
  Dyspnea 4/94 (4%) 3/30 (10%) 1/64 (2%) 0.094
  Palpitations 1/94 (1%) 1/30 (3%) 0/64 (0%) ND
 Physical examination recorded 117 (100%) 44 (100%) 73 (100%) ND
  Cardiac murmurs 3/117 (3%) 2/44 (5%) 1/73 (1%) 0.555
  Heart rate (bpm) 85 (74–100) 97 (82–114) 80 (72–92) < 0.001
  MAP (mmHg) 80 (70–89) 94 (73–107) 100 (94–110) 0.024
 Chest X-ray abnormality 0/114 (0%) 0/42 (0%) 0/72 (0%) ND
 Chest CT scan abnormality 6/83 (7%) 1/33 (3%) 5/50 (10%) 0.395
 ECG abnormality 10/96 (10%) 5/35 (14%) 5/61 (8%) 0.489
 TTE abnormality 1/35 (3%) 1/10 (10%) 0/25 (0%) 0.286
 TnT measured 51 (44%) 22 (50%) 29 (40%) 0.337
  TnT (ng/L) 0 (0–40) 55 (0–283) 0 (0–0) < 0.001
  TnT elevated 13/51 (25%) 13/22 (59%) 0/29 (0%) < 0.001
 Hs-TnT measured 61 (52%) 22 (50%) 39 (53%) 0.849
  Hs-Tnt (ng/L) 10 (5–25) 28 (19–57) 5 (3–11) < 0.001
  Hs-TnT elevated 23/61 (38%) 17/22 (77%) 6/39 (15%) < 0.001
 CK-MB measured 108 (92%) 44 (100%) 64 (88%) 0.013
  CK-MB (µg/L) 8 (4–17) 15 (7–28) 5 (3–10) < 0.001
  CK-MB elevated 57/108 (53%) 33/44 (75%) 24/75 (38%) < 0.001
Diagnostic item at follow-up
 Observation 111 (95%) 43 (98%) 68 (93%) 0.407
 Telemonitoring 83 (71%) 40 (91%) 43 (59%) < 0.001
  Telemonitoring (days) 2 (2–7) 4 (2–10) 2 (2–3) 0.057
 ECG abnormality 3/37 (8%) 1/17 (6%) 2/20 (10%) 1.000
 Time to repeated lab tests (h) 4 (3–6) 4 (3–7) 4 (3–6) 0.833
 TnT measured 48 (41%) 21 (48%) 27 (37%) 0.332
  TnT (ng/L) 0 (0–148) 180 (55–1295) 0 (0–0) < 0.001
  TnT elevated 20 (42%) 18 (86%) 2 (7%) < 0.001
 Hs-TnT measured 52 (44%) 21 (48%) 31 (42%) 0.701
  Hs-Tnt (ng/L) 12 (6–56) 56 (31–127) 8 (5–12) < 0.001
  Hs-TnT elevated 25 (48%) 19 (90%) 6 (19%) < 0.001
 CK-MB measured 95 (81%) 40 (91%) 55 (75%) 0.050
  CK-MB (µg/L) 14 (6–29) 23 (11–43) 9 (4–18) < 0.001
  CK-MB elevated 68 (72%) 37 (93%) 31 (56%) < 0.001
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Twenty-four manuscripts were prospective studies. The total 
sample size of all studies was 7242 patients, of whom 1,048 
(14.5%) were labeled as having a myocardial contusion. The 
diagnostic criteria for myocardial contusion varied across 
studies, but mostly elevated cardiac biomarkers or abnor-
malities seen on electrocardiography or echocardiography, 
or a combination of both.
The risk of bias was judged as low for most studies in 
the domains of patient selection (n = 20), conduct or inter-
pretation of the index test (n = 10), the reference standard 
(n = 10), and patient flow and timing (n = 15; Fig. 4). Appli-
cability concerns were judged as low risk of bias for most 
studies in the domains of patient selection (n = 22), index 
test (n = 14), and reference standard (n = 18).
Sensitivity and specificity of all diagnostic tests used per 
study are shown in Supplemental Figure S2, the pooled val-
ues are shown in Table 5. The enrolled studies did not allow 
pooling of data for hs-TnT. The heterogeneity for all diag-
nostic tests is large, as expressed by a significant Chi-square 
test and I2 value > 50%. This warrants careful interpreta-
tion of the pooled sensitivity and specificity. The pooled 
sensitivity of electrocardiography, troponin I, and CK-MB 
for identifying myocardial contusion varied between 62 and 
71%. Values were 45% for echocardiography and even 38% 
for troponin T. The pooled specificity was generally better 
and ranged from 63% for CK-MB to 85% for troponin T 
and 88% for echocardiography. The area under the summary 
receiver operating curve ranged from 0.71 for CK-MB to 
0.91 for echocardiography.
Discussion
If a patient is presented to the hospital after having sus-
tained blunt thoracic trauma, a myocardial contusion 
should be considered. Results of the current study show 
that the highest sensitivity and specificity are achieved 
when electrocardiography is combined with measuring 
cardiac biomarkers. This combination is best used for rul-
ing in the disorder. Echocardiography is valuable for visual 
inspection of the heart. Chest X-ray and chest CT scan 
are valuable for identifying thoracic injuries and intra-
thoracic bleeding, but are not useful for identifying myo-
cardial contusion.
The gold standard for identifying myocardial contusion 
is pathologic evaluation of the cardiac tissue post-mortem. 
Necrosis of cardiac myocytes is the only confirmative proof.
Since microscopic evaluation is not possible in a clinical 
setting, diagnostic tools such as electrocardiography, echo-
cardiography, and measurement of cardiac biomarkers are 
needed.
The current meta-analysis supports the diagnostic algo-
rithms that were recently published [59–61]. Based on our 
data, we suggest a diagnostic workup as depicted in Fig. 5. 
In line with the Advanced Trauma Life Support guidelines, 
a chest X-ray or CT scan is indicated for patients presenting 
to the hospital after blunt thoracic trauma [62]. These do not 
provide any information on cardiac involvement per se; how-
ever, these tests are required to rule out associated thoracic 
injuries which could serve as an alert to the possibility of a 
Table 3  Diagnostic properties 
of all diagnostic tests performed
Data for sensitivity and specificity are shown as % (95% CI)
Troponin I is not shown, as it was measured in one patient (who had myocardial contusion) at presentation, 
and in none at follow-up
CI confidence interval, CK-MB creatine kinase, muscle and brain isoenzyme, CT computed tomography, 
ECG electrocardiography, Hs-TnT high-sensitive troponin T, TnT troponin T, TTE transthoracic echocardi-
ography
a Median time to follow-up was 4 (2–10) days in patients with a myocardial contusion and 2 (2–3) days in 
patients without myocardial contusion for telemetric observation, and 4 (3–7) h in patients with a myocar-
dial contusion and 4 (3–6) h in patients without myocardial contusion for laboratory tests
Test n Prevalence (95% CI) Sensitivity (95% CI) Specificity (95% CI)
Chest X-ray 114 37% (28–46%) 0% (0–0%) 100% (95–100%)
Chest CT scan 83 40% (29–51%) 3% (0–16%) 90% (78–97%)
ECG at presentation 96 36% (27–47%) 14% (5–30%) 92% (82–97%)
ECG at follow-upa 37 46% (29–63%) 6% (0–29%) 90% (68–99%)
TTE at presentation 35 29% (14–46%) 10% (0–45%) 100% (86–100%)
Cardiac biomarkers
 TnT at presentation 51 43% (29–58%) 59% (36–79%) 100% (88–100%)
 TnT at follow-upa 48 29% (29–59%) 86% (64–97%) 93% (76–99%)
 Hs-TnT at presentation 61 36% (24–49%) 77% (55–92%) 85% (69–94%)
 Hs-TnT at follow-upa 52 40% (27–55%) 90% (70–99%) 81% (63–93%)
 CK-MB at presentation 108 41% (31–51%) 75% (60–87%) 63% (50–74%)
 CK-MB at follow-upa 95 42% (32–53%) 93% (80–98%) 44% (30–57%)
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cardiac injury (e.g., pulmonary contusion or fractures of the 
rib or sternum) [63].
Upon presentation to the hospital, electrocardiography 
and measurement of cardiac biomarkers should routinely 
be done in patients who sustained blunt thoracic trauma. 
An electrocardiogram doubtful of myocardial contusion 
may reveal cardiac arrhythmias indicative for intraven-
tricular conduction disorders, persistent atrial fibrillation, 
premature ventricular complexes, sinus tachycardia, a new 
bundle branch block, or ST depressions or elevations [9, 
64–68]. Despite the fact that electrocardiography has low 
sensitivity and specificity when used alone [45], patients 
with an abnormal electrocardiogram develop more sig-
nificant complications that require treatment [24]. The 
difficulty is to determine if the abnormality on an electro-
cardiogram is a primary event (e.g., an acute coronary syn-
drome that preceded trauma), a direct result of a cardiac 
Fig. 2  Change in cardiac biomarkers over time in patients with myo-
cardial contusion who had their first measurement below the thresh-
old value. Results are shown for a TnT, b hs-TnT, and CK-MB in c 
males and d females. Blue lines indicate patients with measurements 
that remain below the threshold during follow-up. Red dotted lines 
show the threshold above which the cardiac biomarker is considered 
elevated. For CK-MB, males and females have a different threshold
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injury, or a problem caused by the physiological stress of 
severe chest trauma.
Electrocardiography has consistently proven to be the 
best single overall predictor of blunt cardiac trauma [69]. 
However, electrocardiography alone is insufficient to com-
pletely exclude the diagnosis, and in a few rare cases has 
even missed significant blunt chest injuries [23, 47]. On the 
other hand, in our series, two control patients showed car-
diac arrhythmias. Therefore, cardiac biomarkers (troponins 
T and I and CK-MB) should also be measured. Although 
the usefulness of cardiac biomarkers is unclear [36, 47], 
elevated troponin levels have been associated with increased 
Table 4  Adverse events and 
mortality of patients with versus 
without myocardial contusion
Data are shown as n (%)
ND not determined, PVC premature ventricular complexes
a This is excluding one patient for whom an electrocardiography before trauma already showed atrial fibril-
lation
Parameter Overall (n = 117) Myocardial contu-
sion (n = 44)
No myocardial contu-
sion (n = 73)
p value
Adverse events 18 (15%) 15 (34%) 3 (4%)a < 0.001
 Arrhythmias 14 (12%) 13 (30%) 1 (1%)a < 0.001
  Atrial fibrillation 7 (6%) 7 (16%) 0 (0%) ND
  PVC 2 (2%) 2 (5%) 0 (0%) ND
  Atrial flutter 1 (1%) 1 (2%) 0 (0%) ND
 Hypotension 8 (7%) 6 (14%) 2 (3%) 0.051
 Cardiogenic shock 1 (1%) 1 (2%) 0 (0%) 0.376
Mortality 7 (6%) 4 (9%) 3 (4%) 0.423
Fig. 3  Flowchart of literature search
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mortality in patients with blunt thoracic trauma [42]. 
Although sensitivity and specificity of cardiac biomarkers 
vary largely across studies on myocardial contusion [2, 3, 8, 
14, 21–23, 35–37, 41–58], our results show that sensitivity 
and specificity of the cardiac biomarkers is higher than that 
of echocardiography. Since other cardiac conditions may 
also result in cardiac biomarker elevation, cardiac biomark-
ers should be combined with either electrocardiography or 
echocardiography. Elevation of cardiac biomarkers can also 
be the result of hypovolemic shock, which is commonly seen 
in patients with significant chest trauma.
Electrocardiogram abnormalities or rising troponin values 
should prompt further evaluation using transthoracic echo-
cardiography (TTE). This may reveal left or right ventricu-
lar systolic dysfunction, pericardial effusion with suspected 
tamponade, ventricular septal defect, or possible trauma-
induced valvular abnormalities [70].
Results from the electrocardiography (and echocardiog-
raphy) and cardiac biomarkers support the subsequent diag-
nostic necessities and monitoring. Patients with abnormali-
ties on the electrocardiography (or echocardiography) that 
are not explained by (non-)STEMI or by cardiac diseases 
that were already present pre-trauma, should be considered 
suspect for myocardial contusion. If cardiac biomarkers 
are also elevated, measurement of these markers should be 
repeated after 3 h. In addition, telemonitoring is required for 
early knowledge of possible development of life-threaten-
ing arrhythmias or other complications. The patient data in 
this study confirm the relevance of this as 13 patients with 
myocardial contusion developed some form or arrhythmia 
over time. Cardiac monitoring should last at least 24–48 h 
because life-threatening ventricular arrhythmias, cardiac 
failure due to valve damage, cardiac tamponade due to a 
wall rupture, or acute coronary syndrome due to coronary 
artery dissection may develop within this period [35, 60, 
67, 71, 72].
If cardiac biomarkers are not elevated in patients with 
electrocardiography abnormalities, the biomarkers should 
be measured again after 3 h, as they may become positive. If 
the cardiac biomarkers remain negative and no other clinical 
suspicion of myocardial contusion has emerged, the diagno-
sis can be rejected. Emerging clinical suspicion or elevated 
markers at follow-up, on the other hand, supports the pres-
ence of myocardial contusion. Telemonitoring is indicated 
in those patients.
If both cardiac biomarkers are not elevated and the elec-
trocardiography shows no abnormalities, myocardial contu-
sion is unlikely. It was shown previously that patients with 
a normal electrocardiogram in conjunction with normal 
levels of troponin can be safely discharged home [60, 67, 
68]. However, our patient data show that clinical observa-
tion without telemonitoring may be needed for patients who 
have other traumatic thoracic diagnoses such as rib fractures.
The current study has several limitations. The most obvi-
ous limitations are the retrospective nature of the cohort 
study and the lack of a gold standard in both the cohort study 
and all studies in the literature review. Personal opinion of 
the treatment team may have led to false positive of false 
negative results for myocardial contusion. These differences 
in diagnostic criteria used, variation in biomarker cut off 
values, as well as differences in study population may have 
contributed to the heterogeneity across studies in the meta-
analysis. This may have resulted in differences in sensitivity 
Fig. 4  Risk of bias and applicability concerns graph. Authors’ judge-
ments about each domain presented as percentages across included 
studies
Table 5  Pooled sensitivity and specificity of all diagnostic tests for identifying myocardial contusion for all studies identified in the systematic 
literature review
Test Sensitivity Specificity AUC 
Chi2 (p) I2 (%) Pooled % (95% CI) Chi2 (p) I2 (%) Pooled % (95% CI)
Electrocardiography 165 (< 0.001) 93 71% (66–75%) 262 (< 0.001) 96 75% (72–77%) 0.86 (0.04)
Echocardiography 43 (< 0.001) 84 45% (37–53%) 23 (< 0.001) 69 88% (83–92%) 0.91 (0.08)
Cardiac biomarkers
 Troponin T 26 (0.001) 88 38% (27–50%) 61 (< 0.001) 95 85% (83–87%) 0.88 (0.17)
 Troponin I 33 (< 0.001) 79 62% (53–69%) 127 (< 0.001) 95 76% (73–80%) 0.80 (0.07)
 CK-MB 61 (< 0.001) 86 66% (60–72%) 291 (< 0.001) 97 63% (59–67%) 0.71 (0.06)
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Fig. 5  Diagnostic algorithm for patients with blunt thoracic injuries with suspected myocardial contusion
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and specificity of the different diagnostic tests across the 
published as well as our cohort study. This heterogeneity 
also warrants careful interpretation of the pooled sensitivity 
and specificity.
Conclusions
Data from the current study support that initial diagnostic 
workup in patients who presented to a hospital after blunt 
thoracic trauma should consist of electrocardiography and 
measurement of cardiac biomarkers. If the electrocardiogra-
phy shows abnormalities indicative of myocardial contusion 
and/or cardiac biomarkers are elevated at presentation or 
become elevated within the subsequent 3 h, echocardiogra-
phy and telemonitoring are indicated. If electrocardiography 
is normal and cardiac biomarkers remain negative, clini-
cal observation may suffice. Further prospective studies are 
needed to refine the proposed diagnostic scheme.
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